Oruka Therapeutics, Inc.
Clinical trials sponsored by Oruka Therapeutics, Inc., explained in plain language.
-
Psoriasis patients get extended treatment in new safety study
Disease control Recruiting nowThis study continues testing an investigational psoriasis treatment called ORKA-001 to see how safe and effective it is over a longer period. It's for adults with moderate-to-severe plaque psoriasis who already participated in an earlier trial with this medication. Participants w…
Phase: PHASE2 • Sponsor: Oruka Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New drug trial aims to clear severe skin plaques
Disease control Recruiting nowThis study is testing a new drug called ORKA-001 to see if it can clear skin plaques in people with moderate-to-severe plaque psoriasis. About 160 adults will receive either the drug or a placebo to find the best dose and check how safe it is. The main goal is to see how many peo…
Phase: PHASE2 • Sponsor: Oruka Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC